522
Views
8
CrossRef citations to date
0
Altmetric
Review Articles

The pathogenic microbial flora and its antibiotic susceptibility pattern in odontogenic infections

, , , , &
Pages 340-355 | Received 27 Dec 2018, Accepted 25 Mar 2019, Published online: 21 May 2019

References

  • Allison K, Brynildsen M, Collins J. 2011. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature. 473:216–220.
  • Arteagoitia M, Barbier L, Santamaría J, Santamaría G, Ramos E. 2016. Efficacy of amoxicillin and amoxicillin/clavulanic acid in the prevention of infection and dry socket after third molar extraction. A systematic review and meta-analysi. Med Oral. 21(4):e494–504.
  • American Academy of Pediatric Dentistry Council on Clinical Affairs. 2013. Guidelines on use of antibiotic therapy for pediatric dental patients. Reference Manual 2013–2014. Pediatr Dent. 35:546–549.
  • Akst LM, Albani BJ, Strome M. 2005. Subacute infratemporal fossa cellulitis with subsequent abscess formation in an immunocompromised patient. Am J Otolaryngol. 26:35–38.
  • Antunez C, Blanca-Lopez N, Torres MJ, Mayorga C, Perez-Inestrosa E, Montañez MI, Fernandez T, Blanca M. 2006. Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins. J Allergy Clin Immunol. 117:404–410.
  • Appelbaum PC, Spangler SK, Jacobs MR. 1990. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers. Antimicrob Agents Chemother. 34:1546–1550.
  • Bahl R, Sandhu S, Singh K, Sahai N, Gupta M. 2014. Odontogenic infections: microbiology and management. Contemp Clin Dent. 5:307–311.
  • Barcus VA, Ghanekar K, Yeo M, Coffey TJ, Dowson CG. 1995. Genetics of high level penicillin resistance in clinical isolates of Streptococcus pneumoniae. FEMS Microbiol Lett. 126:299–303.
  • Bartold PM, Du Bois AH, Gannon S, Haynes DR, Hirsch RS. 2013. Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis. Inflammopharmacology. 21:321–338.
  • Bascones Martínez A, Aguirre Urízar JM, Bermejo Fenoll A, Blanco Carrión A, Gay-Escoda C, González-Moles MA, Gutiérrez Pérez JL, Jiménez Soriano Y, Liébana Ureña J, López Marcos JF. 2004. Consensus statement on antimicrobial treatment of odontogenic bacterial infections. Med Oral Patol Oral Cir Bucal. 9:369–376. 363–369.
  • Bhattacharya S. 2010. The facts about penicillin allergy: a review. J Adv Pharm Technol Res. 1:11–17.
  • Beovic B. 2006. The issue of antimicrobial resistance in human medicine. Int J Food Microbiol. 112:280–287.
  • Becker D. 2013. Antimicrobial drugs. Anesth Prog. 60:111–122.
  • Berini L, Gay C. 2004. Normas generales de tratamiento de la infección odontogénica. Antibioticoterapia. Profilaxis de las infecciones postquirúrgicas y a distancia. En: Gay C, Berini L, editors. Tratado de Cirugía Bucal. Tomo I. Madrid (Spain): Ergón. p. 617–638.
  • Berini L, Gay Escoda C. 1999. La infección odontogénica: concepto, etiopatogenia, bacteriología y clínica. En: Gay Escoda C, Berini L, editors. Cirugía Bucal. Madrid (Spain): Ergón. p. 597–621.
  • Boffano P, Roccia F, Pittoni D, Di Dio D, Forni P, Gallesio C. 2012. Management of 112 hospitalized patients with spreading odontogenic infections: correlation with DMFT and oral health impact profile 14 indexes. Oral Surg Oral Med Oral Pathol Oral Radiol.113:207–213.
  • Boyanova L, Kolarov R, Gergova G, Deliverska E, Madjarov J, Marinov M, Mitov I. 2006. Anaerobic bacteria in 118 patients with deep-space head and neck infections from the University Hospital of Maxillofacial Surgery, Sofia, Bulgaria. J Med Microbiol. 55:1285–1289.
  • Boyanova L, Kolarov R, Gergova G, Dimitrova L, Mitov I. 2010. Trends in antibiotic resistance in Prevotella species from patients of the University Hospital of Maxillofacial Surgery, Sofia, Bulgaria, in 2003–2009. Anaerobe. 16:489–492.
  • Brescó-Salinas M, Costa-Riu N, Berini-Aytés L, Gay-Escoda C. 2006. Antibiotic susceptibility of the bacteria causing odontogenic infections. Med Oral Patol Oral Cir Bucal. 1:11E70–11E75.
  • Brook I. 1988. Beta-lactamase-producing bacteria in head and neck infection. Laryngoscope. 98:428–431.
  • Brook I. 2002. Anaerobic bacteria in upper respiratory tract and other head and neck infections. Ann Otol Rhinol Laryngol. 111:430–440.
  • Cachovan G, Boger RH, Giersdorf I, Hallier O, Streichert T, Haddad M, Platzer U, Schon G, Wegscheider K, Sobottka I. 2011. Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial. Antimicrob Agents Chemother. 55:1142–1147.
  • Chardin H, Yasukawa K, Nouacer N, Plainvert C, Aucouturier P, Ergani A, Descroix V, Toledo-Arenas R, Azerad J, Bouvet A. 2009. Reduced susceptibility to amoxicillin of oral streptococci following amoxicillin exposure. J Med Microbiol. 58(Pt 8):1092–1097.
  • Chow AW. 2005. Infections of the oral cavity, neck, and head. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 6th ed. Philadelphia (PA): Elsevier, Churchill Livingstone; p. 787–802.
  • Chunduri NS, Madasu K, Goteki VR, Karpe T, Reddy H. 2012. Evaluation of bacterial spectrum of orofacial infections and their antibiotic susceptibility. Ann Maxillofac Surg. 2:46–50.
  • Dahlberg C, Chao L. 2003. Amelioration of the cost of conjugative plasmid carriage in Eschericha coli K12. Genetics. 165:1641–1649.
  • Davies J. 1994. Inactivation of antibiotics and the dissemination of resistance genes. Science. 264:375.
  • DeAngelis AF, Barrowman RA, Harrod R, Nastri AL. 2014. Review article: Maxillofacial emergencies: oral pain and odontogenic infections. Emerg Med Australas. 26:336–334.
  • Diz Dios P, Tomás Carmona I, Limeres Posse J, Medina Henríquez J, Fernández Feijoo J, Alvarez Fernández M. 2006. Comparative efficacies of amoxicillin, clindamycin, and moxifloxacin in prevention of bacteremia following dental extractions. Antimicrob Agents Chemother. 50:2996–3002.
  • Dogan B, Schukken YH, Santisteban C, Boor KJ. 2005. Distribution of serotypes and antimicrobial resistance genes among Streptococcus agalactiae isolates from bovine and human hosts. J Clin Microbiol. 43:5899–5906.
  • Eckert AW, Maurer P, Wilhelms D, Schubert J. 2005. [Bacterial spectra and antibiotics in odontogenic infections. Renaissance of the penicillins?] Mund Kiefer Gesichtschir. 9:377–383.
  • Eisenreich W, Dandekar T, Heesemann J, Goebel W. 2010. Carbon metabolism of intracellular bacterial pathogens and possible links to virulence. Nat Rev Microbiol. 8:401–412.
  • Ellison SJ. 2009. The role of phenoxymethylpenicillin, amoxicillin, metronidazole and clindamycin in the management of acute dentoalveolar abscesses-a review. Br Dent J. 206:357–362.
  • Farmahan S, Tuopar D, Ameerally PJ. 2015. A study to investigate changes in the microbiology and antibiotic sensitivity of head and neck space infections. Surgeon. 13:316–320.
  • Fating N, Saikrishna D, Vijay Kumar G, Shetty S, Raghavendra Rao M. 2014. Detection of Bacterial Flora in Orofacial Space Infections and Their Antibiotic Sensitivity Profile. J Maxillofac Oral Surg. 13:525–532.
  • Flynn TR. 2011. What are the antibiotics of choice for odontogenic infections, and how long should the treatment course last?. Oral Maxillofac Surg Clin North Am. 23:519–536.
  • Flynn TR, Shanti RM, Levi MH, Adamo AK, Kraut RA, Trieger N. 2006. Severe odontogenic infections, part 1: prospective report. J Oral Maxillofac Surg. 64:1093–1103.
  • Gbolahan OO, Owotade FJ, Fatusi OA, Aboderin AO, Akinwande JA, Abdulrasheed AR. 2011. Bacteriologic features and antimicrobial resistance of organisms associated with extracted teeth: findings from a Nigerian university teaching hospital. West Afr J Med. 30:436–441.
  • Gill Y, Scully C. 1990. Orofacial odontogenic infections: review of microbiology and current treatment. Oral Surg Oral Med Oral Pathol. 70:155–158.
  • Gordon KA, Beach ML, Biedenbach DJ, Jones RN, Rhomberg PR, Mutnick AH. 2002. Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997–2000)). Diagn Microbiol Infect Dis. 43:157–162.
  • Gordon NC, Connelly S. 2003. Management of head and neck infections in the immunocompromised patient. Oral Maxillofac Surg Clin North Am. 15:103–110.
  • Har-El G, Aroesty JH, Shaha A, Lucente FE. 1994. Changing trends in deep neck abscess. A retrospective study of 110 patients. Oral Surg Oral Med Oral Pathol. 77:446–450.
  • Hawkey PM. 2000. Mechanisms of resistance to antibiotics. Intensive Care Med. 26:S9.
  • Heim N, Faron A, Wiedemeyer V, Reich R, Martini M. 2017. Microbiology and antibiotic sensitivity of head and neck space infections of odontogenic origin. Differences in inpatient and outpatient management. J Craniomaxillofac Surg. 45:1731–1735.
  • Heimdahl A, Nord CE. 1985. Treatment of orofacial infections of odontogenic origin. Scand J Infect Dis Suppl. 46:101–105.
  • Herrera D, Roldan S, Gonzalez I, Sanz M. 2000. The periodontal abscess (I). Clinical and microbiological findings. J Clin Periodontol. 27:387–394.
  • Hirsch R, Deng H, Laohachai MN. 2012. Azithromycin in periodontal treatment: more than an antibiotic. J Periodont Res. 47:137–148.
  • Huang TT, Tseng FY, Yeh TH, Hsu CJ, Chen YS. 2006. Factors affecting the bacteriology of deep neck infection: a retrospective study of 128 patients. Acta Otolaryngol. 126:396–401.
  • Hunt DE, Meyer RA. 1983. Continued evolution of the microbiology of oral infections. J Am Dent Assoc. 107:52–54.
  • Hwang T, Antoun JS, Lee KH. 2011. Features of odontogenic infections in hospitalised and non-hospitalised settings. Emerg Med J. 28:766–769.
  • Igoumenakis D, Gkinis G, Kostakis G, Mezitis M, Rallis G. 2014. Severe odontogenic infections: causes of spread and their management. Surg Infect (Larchmt)). 15:64–68.
  • Jousimies-Somer H, Summanen P, Citron D, Baron EJ, Wexler HM, Finegold SM. 2002. Wadsworth anaerobic bacteriology manual. Belmont (CA): Star Publishing.
  • Juncar M, Lung T, Onisor F. 2009. Diffuse odontogenic infections of cephalic extremity soft tissue—study over a period of 5 years (2004–2008). Int J Oral Maxillofac Surg. 38:477.
  • Jungermann GB, Burns K, Nandakumar R, Tolba M, Venezia RA, Fouad AF. 2011. Antibiotic resistance in primary and persistent endodontic infections. J Endod. 37:1337–1344.
  • Kannangara DW, Thadepalli H, McQuirter JL. 1980. Bacteriology and treatment of dental infections. Oral Surg Oral Med Oral Pathol. 50:103.
  • Kanoh S, Rubin BK. 2010. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev. 23:590–615.
  • Kaptan R, Haznedaroglu F, Basturk F, Kayahan M. 2013. Treatment approaches and antibiotic use for emergency dental treatment in Turkey. Ther Clin Risk Manag. 9:443–449.
  • Kardos N, Demain AL. 2011. Penicillin: the medicine with the greatest impact on therapeutic outcomes. Appl Microbiol Biotechnol. 92:677–687.
  • Karibasappa GN, Sujatha A. 2013. Antibiotic resistance-a concern for dentists? IOSRJDMS. 13:112–118.
  • Khan K, Muennig P, Behta M, Zivin JG. 2002. Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States. N Engl J Med. 347:1850–1859.
  • Khemaleelakul S, Baumgartner JC, Pruksakorn S. 2002. Identification of bacteria in acute endodontic infections and their antimicrobial susceptibility. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 94:746–755.
  • King D, Sobhanifar S, Strynadka N. 2016. One ring to rule them all: Current trends in combating bacterial resistance to the β-lactams. Protein Sci. 25:787–803.
  • Kirkwood KL. 2003. Update on antibiotics used to treat orofacial infections. Alpha Omegan. 96:28–34.
  • Kityamuwesi R, Muwaz L, Kasangaki A, Kajumbula H, Rwenyonyi CM. 2015. Characteristics of pyogenic odontogenic infection in patients attending Mulago Hospital, Uganda: a cross-sectional study. BMC Microbiol. 25:46.
  • Koeth LM, Good CE, Appelbaum PC, Goldstein EJ, Rodloff AC, Claros M, Dubreuil LJ. 2004. Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents. J Antimicrob Chemother. 53:1039–1044.
  • Kohanski M, Dwyer D, Hayete B, Law-Rence C, Collins J. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell. 130:797–810.
  • Kohli M, Mathur A, Kohli M, Siddiqui SR. 2009. In vitro evaluation of microbiological flora of orofacial infections. J Maxillofac Oral Surg. 8:329–333.
  • Konde S, Jairam LS, Peethambar P, Noojady SR, Kumar NC. 2016. Antibiotic overusage and resistance: A cross-sectional survey among pediatric dentists. J Indian Soc Pedod Prev Dent. 34:145–151.
  • Könönen E, Nyfors S, Mättö J, Asikainen S, Jousimies-Somer H. 1997. βlactamase production by oral pigmented Prevotella species isolated from young children. Clin Infect Dis. 25:S272–S274.
  • Krishnan V, Johnson JV, Helfrick JF. 1993. Management of maxillofacial infections: A review of 50 cases. J Oral Maxillofac Surg. 51:868.
  • Kuriyama T, Absi EG, Williams DW, Lewis MA. 2005. An outcome audit of the treatment of acute dentoalveolar infection: impact of penicillin resistance. Br Dent J. 198:759–763.
  • Kuriyama T, Nakagawa K, Karasawa T, Saiki Y, Yamamoto E, Nakamura S. 2000. Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 90:600–608.
  • Kuriyama T, Nakagawa K, Karasawa T, Saiki Y, Yamamoto E, Nakamura S. 2000. Past administration of beta-lactam antibiotics and increase in the emergence of beta-lactamase-producing bacteria in patients with orofacial odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 89:186–192.
  • Kwiatkowska B, Maślińska M. 2012. Macrolide therapy in chronic inflammatory diseases. Mediators Inflamm. 2012:636157.
  • Lancaster H, Bedi R, Wilson M, Mullany P. 2005. The maintenance in the oral cavity of children of tetracycline-resistant bacteria and the genes encoding such resistance. J Antimicrob Chemother. 56:524–531.
  • Lee JK, Kim HD, Lim SC. 2007. Predisposing factors of complicated deep neck infection: an analysis of 158 cases. Yonsei Med J. 48:55–56.
  • Lee QU. 2014. Use of cephalosporins in patients with immediate penicillin hypersensitivity: cross-reactivity revisited. Hong Kong Med J. 20:428–436.
  • Levin BR, Lipsitch M, Perrot V, Schrag S, Antia R, Simonsen L, Walker NM, Stewart FM. 1997. The population genetics of antibiotic resistance. Clin Infect Dis off Publ Infect Dis Soc Am. 24:S9–S16.
  • Lewis MA, Parkhurst CL, Douglas CW, Martin MV, Absi EG, Bishop PA, Jones SA. 1995. Prevalence of penicillin resistant bacteria in acute suppurative oral infection. J Antimicrob Chemother. 35:785–791.
  • Lewis MAO, MacFarlane TW, McGowan DA. 1990. A microbiological and clinical review of the acute dentoalveolar abscess. Br J Oral Maxillofac Surg. 28:359.
  • Liau I, Han J, Bayetto K, May B, Goss A, Sambrook P, Cheng A. 2018. Antibiotic resistance in severe odontogenic infections of the South Australian population: a 9-year retrospective audit. Aust Dent J. 63:187–192.
  • Lins RX, de Oliveira Andrade A, Hirata Junior R, Wilson MJ, Lewis MA, Williams DW, Fidel RA. 2013. Antimicrobial resistance and virulence traits of Enterococcus faecalis from primary endodontic infections. J Dent. 41:779–786.
  • Marciano DC, Karkouti OY, Palzkill T. 2007. A fitness cost associated with the antibiotic resistance enzyme SME-1 beta-lactamase. Genetics. 176:2381–2392.
  • Marcusson LL, Frimodt-Møller N, Hughes D. 2009. Interplay in the selection of fluoroquinolone resistance and bacterial fitness. PLoS Pathog. 5:e1000541.
  • Maestre-Vera JR. 2004. Opciones terapéuticas en la infección de origen odontogénico. Med Oral Patol Oral Cir Bucal. 9(Supp l):19–31.
  • Marra F, George D, Chong M, Sutherland S, Patrick D. 2016. Antibiotic prescribing by dentists has increased: Why? J Am Dent Assoc. 147:320–327.
  • Marty-Ane CH, Berthet JP, Alric P, Pegis JD, Rouviere P, Mary H. 1999. Management of descending necrotizing mediastinitis: an aggressive treatment for an aggressive disease. Ann Thorac Surg. 68:212–217.
  • Melnyk AH, Wong A, Kassen R. 2015. The fitness costs of antibiotic resistance mutations. Evol Appl. 8:273–283.
  • Moenning JE, Nelson CL, Kohler RB. 1989. The microbiology and chemotherapy of odontogenic infections. J Oral Maxillofac Surg. 47:976–985.
  • Moghimi M, Baart JA, Karagozoglu KH, Forouzanfar T. 2013. Spread of odontogenic infections: a retrospective analysis and review of the literature. Quintessence Int. 44:351–361.
  • Moraes LC, Só MVR, Dal Pizzol T. d S, Ferreira MBC, Montagner F. 2015. Distribution of genes related to antimicrobial resistance in different oral environments: a systematic review. J Endod. 41:434–441.
  • Musoke RN, Revathi G. 2000. Emergence of multidrug-resistant gram-negative organisms in a neonatal unit and the therapeutic implications. J Trop Pediatr. 46:86–91.
  • Murima P, McKinney J, Pethe K. 2014. Targeting bacterial central metabolism for drug development. Chem Biol. 21:1423–1432.
  • Nakayama A, Takao A. 2003. Beta-Lactam resistance in Streptococcus mitis isolated from saliva of healthy subjects. J Infect Chemother. 9:321–327.
  • Neu HC. 1992. The crisis in antibiotic resistance. Science. 257:1064–1073.
  • Newman MG, Goodman AD. 1989. Oral and dental infections. In: Finegold SM, George WL, editors. Anaerobic infections in human. San Diego (CA): Academic Press; p. 233–261.
  • Oberoi SS, Dhingra C, Sharma G, Sardana D. 2015. Antibiotics in dental practice: How justified are we. Int Dent J. 65:4–10.
  • Opitz D, Camerer C, Camerer DM, Raguse JD, Menneking H, Hoffmeister B, Adolphs N. 2015. Incidence and management of severe odontogenic infections-a retrospective analysis from 2004 to 2011. J Craniomaxillofac Surg. 43:285–289.
  • Parhiscar A, Har-El G. 2001. Deep neck abscess: A retrospective review of 210 cases. Ann Otol Rhinol Laryngol. 110:1051–1054.
  • Ţenţ PA, Juncar M, Muresan O, Arghir O, Iliescu D, Onișor F. 2018. Post-traumatic occipital psoriatic plaque complicated by extensive necrotizing fasciitis of the head and neck: a case report and literature review. J Int Med Res. 0:1–7.
  • Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, Perletti G, Verleden GM, Vos R. 2014. Azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacol Ther. 143:225–245.
  • Peltroche H, Reichhart E, Schmitt W, Lutticken R. 2000. Investigation of infectious organisms causing pericoronaritis of the mandibular third molar. J Oral Maxillofac Surg. 58:611–616.
  • Peng B, Su Y, Li H, Han Y, Guo C, Tian Y, Peng X. 2015. Exogenous Alanine and/or Glucose plus Kanamycin Kills Antibiotic-Resistant Bacteria. Cell Metab.21(this issue):249–261.
  • Plum AW, Mortelliti AJ, Walsh RE. 2018. Microbial flora and antibiotic resistance in odontogenic abscesses in Upstate New York. Ear Nose Throat J. 97:E27–E31.
  • Poeschl PW, Spusta L, Russmueller G, Seemann R, Hirschl A, Poeschl E, Klug C, Ewers R. 2010. Antibiotic susceptibility and resistance of the odontogenic microbiological spectrum and its clinical impact on severe deep space head and neck infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 110:151–156.
  • Poveda Roda R, Bagan JV, Sanchis Bielsa JM, Carbonell Pastor E. 2007. Antibiotic use in dental practice. A review. Med Oral Patol Oral Cir Bucal. 12:E186–E192.
  • Rasmussen BA, Bush K, Tally FP. 1997. Antimicrobial resistance in anaerobes. Clin Infect Dis. 24:S110–eS120.
  • Rastenienė R, Pūrienė A, Aleksejūnienė J, Pečiulienė V, Zaleckas L. 2015. Odontogenic maxillofacial infections: a ten-year retrospective analysis. Surg Infect (Larchmt)). 16:305–312.
  • Rega AJ, Aziz SR, Ziccardi VB. 2006. Microbiology and antibiotic sensitivities of head and neck space infections of odontogenic origin. J Oral Maxillofac Surg. 64:1377–1380.
  • Restrepo MI, Anzueto A. 2014. Macrolide antibiotics for prevention of chronic obstructive pulmonary disease exacerbations: are we there yet? Am J Respir Crit Care Med. 190:1–2.
  • Robertson D, Smith AJ. 2009. The microbiology of the acute dental abscess. J Med Microbiol. 58(2):155–162.
  • Rocas IN, Siqueira JF, Jr. 2012. Antibiotic resistance genes in anaerobic bacteria isolated from primary dental root canal infections. Anaerobe. 18:576–580.
  • Rodríguez-Avial I, Rodríguez-Avial C, Culebras E, Benítez A, Picazo JJ. 2001. Distribution of mef(A) and erm(B) genes in macrolide-resistant blood isolates of viridans group streptococci. J Antimicrob Chemother. 47:727–728.
  • Romano A, Gaeta F, Valluzzi RL, Maggioletti M, Zaffiro A, Caruso C, Quaratino D. 2015. IgE-mediated hypersensitivity to cephalosporins: Cross-reactivity and tolerability of alternative cephalosporins. J Allergy Clin Immunol. 136:685–691.e3.
  • Sakaguchi M, Sato S, Ishiyama T, Katsuno S, Taguchi K. 1997. Characteristics and management of deep neck infections. Int J Oral Maxillofac Surg. 26:131–134.
  • Sánchez R, Mirada E, Arias J, Paño JR, Burgueño M. 2011. Severe odontogenic infections: epidemiological, microbiological and therapeutic factors. Med Oral Patol Oral. 16:e670–e676.
  • Sandner A, Börgermann J. 2011. Update on necrotizing mediastinitis: causes, approaches to management, and outcomes. Curr Infect Dis Rep. 13:278–286.
  • Sandor GK, Low DE, Judd PL, Davidson RJ. 1998. Antimicrobial treatment options in the management of odontogenic infections. J Can Dent Assoc. 64:508–514.
  • Sands T, Pynn BR, Katsikeris N. 1995. Odontogenic infections: Part two. Microbiology, antibiotics and management. Oral Health. 85:11.
  • Satcher D. 1995. Emerging infections: Getting ahead of the curve. Emerg Infect Dis. 1:1.
  • Sato FR, Hajala FA, Freire Filho FW, Moreira RW, de Moraes M. 2009. Eight-year retrospective study of odontogenic origin infections in a postgraduation program on oral and maxillofacial surgery. J Oral Maxillofac Surg. 67:1092.
  • Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P. 2008. The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol Rev. 32:234–258.
  • Seppälä H, Haanperä M, Al-Juhaish M, Järvinen H, Jalava J, Huovinen P. 2003. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora. J Antimicrob Chemother. 52:636–644.
  • Seppanen L, Lauhio A, Lindqvist C, Suuronen R, Rautemaa R. 2008. Analysis of systemic and local odontogenic infection complications requiring hospital care. J Infect. 57:116–122.
  • Sethi DS, Stanley RE. 1994. Deep neck abscess e changing trends. J Laryngol Otol. 108:138.
  • Seville LA, Patterson AJ, Scott KP, Mullany P, Quail MA, Parkhill J, Ready D, Wilson M, Spratt D, Roberts AP. 2009. Distribution of tetracycline and erythromycin resistance genes among human oral and fecal metagenomic DNA. Microb Drug Resist. 15:159–166.
  • Shah A, Ramola V, Nautiyal V. 2016. Aerobic microbiology and culture sensitivity of head and neck space infection of odontogenic origin. Natl J Maxillofac Surg. 7:56–61.
  • Shakya N, Sharma D, Newaskar V, Agrawal D, Shrivastava S, Yadav R. 2018. Epidemiology, microbiology and antibiotic sensitivity of odontogenic space infections in Central India. J Maxillofac Oral Surg. 17:324–331.
  • Singh M, Kambalimath DH, Gupta KC. 2014. Management of odontogenic space infection with microbiology study. J Maxillofac Oral Surg. 13:133–139.
  • Sixou JL, Magaud C, Jolivet-Gougeon A, Cormier M, Bonnaure-Mallet M. 2003. Microbiology of mandibular third molar pericoronitis: incidence of beta-lactamase-producing bacteria. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 95:655–659.
  • Skucaite N, Peciuliene V, Vitkauskiene A, Machiulskiene V. 2010. Susceptibility of endodontic pathogens to antibiotics in patients with symptomatic apical periodontitis. J Endod. 36:1611–1616.
  • Smith A, Jackson MS, Kennedy H. 2004. Antimicrobial susceptibility of viridans group streptococcal blood isolates to eight antimicrobial agents. Scand J Infect Dis. 36:259–263.
  • Smith AJ, Jackson MS, Bagg J. 2001. The ecology of Staphylococcus species in the oral cavity. J Med Microbiol. 50:940–946.
  • Soares GMS, Figueiredo LC, Faveri M, Cortelli SC, Duarte PM, Feres M. 2012. Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs. J Appl Oral Sci. 20:295–304.
  • Sobottka I, Cachovan G, Sturenburg E, Ahlers MO, Laufs R, Platzer U, Mack D. 2002. In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses. Antimicrob Agents Chemother. 46:4019–4021.
  • Sommer MO, Church GM, Dantas G. 2010. The human microbiome harbors a diverse reservoir of antibiotic resistance genes. Virulence. 1:299–303.
  • Stavru F, Bouillaud F, Sartori A, Ricquier D, Cossart P. 2011. Listeria monocytogenes transiently alters mitochondrial dynamics during infection. Proc Natl Acad Sci USA. 108:3612–3617.
  • Stefanopoulos PK, Kolokotronis AE. 2004. The clinical significance of anaerobic bacteria in acute orofacial odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 98:398–408.
  • Storoe W, Haug RH, Lillich TT. 2001. The changing face of odontogenic infections. J Oral Maxillofac Surg. 59:739.
  • Sundqvist G. 1994. Taxonomy, ecology, and pathogenicity of the root canal flora. Oral Surg Oral Med Oral Pathol. 78:522–530.
  • Tavakoli M, Bagheri A, Faraz M, Salehirad S, Roghaee S. 2013. Orbital cellulitis as a complication of mandibular odontogenic infection. Ophthalmic Plast Reconstr Surg. 29:e5–e7.
  • Testerman TL, Conn PB, Mobley HLT, McGee DJ. 2006. Nutritional requirements and antibiotic resistance patterns of Helicobacter species in chemically defined media. J Clin Microbiol. 44:1650–1658.
  • Tomás I, Tomás M, Alvarez M, Velasco D, Potel C, Limeres J, Diz P. 2007. Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials. Oral Microbiol Immunol. 22:298–303.
  • Topazian RG, Goldberg MH, Hupp JR. 2002. Oral and maxillofacial infections, 4th edn. Philadelphia (PA): W.B.Saunders.
  • Toprak E, Veres A, Michel J-B, Chait R, Hartl DL, Kishony R. 2012. Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet. 44:101–105.
  • Tzermpos F, Iatrou I, Papadimas C, Pistiki A, Georgitsi M, Giamarellos-Bourboulis EJ. 2013. Function of blood monocytes among patients with orofacial infections. J Craniomaxillofac Surg. 41:88–91.
  • van Winkelhoff AJ, Winkel EG, Barendregt D, Dellemijn-Kippuw N, Stijne A, van der Velden U. 1997. beta-Lactamase producing bacteria in adult periodontitis. J Clin Periodontol. 24:538–543.
  • Walia IS, Borle RM, Mehendiratta D, Yadav AO. 2014. Microbiology and Antibiotic Sensitivity of Head and Neck Space Infections of Odontogenic Origin. J Maxillofac Oral Surg. 13:16–21.
  • Wang J, Ahani A, Pogrel MA. 2005. A five-year retrospective study of odontogenic maxillofacial infections in a large urban public hospital. Int J Oral Maxillofac Surg. 34:646–649.
  • Wang HH, Manuzon M, Lehman M, Wan K, Luo H, Wittum TE, Yousef A, Bakaletz LO. 2006. Food commensal microbes as a potentially important avenue in transmitting antibiotic resistance genes. FEMS Microbiol Lett. 254:226–231.
  • Warnke PH, Becker ST, Springer IN, Haerle F, Ullmann U, Russo PA, Wiltfang J, Fickenscher H, Schubert S. 2008. Penicillin compared with other advanced broad spectrum antibiotics regarding antibacterial activity against oral pathogens isolated from odontogenic abscesses. J Craniomaxillofac Surg. 36:462–467.
  • Wise R, Hart T, Cars O, Streulens M, Helmuth R, Huovinen P, Sprenger M. 1998. Antimicrobial resistance. Is a major threat to public health. BMJ. 317:609–610.
  • Zaleckas L, Rasteniene R, Rimkuviene J, Seselgyte R. 2010. Retrospective analysis of cellulitis of the floor of the mouth. Stomatologija. 12:23–27.
  • Zampieri M, Enke T, Chubukov V, Ricci V, Piddock L, Sauer U. 2017. Metabolic constraints on the evolution of antibiotic resistance. Mol Syst Biol. 13:917.
  • Zapun A, Contreras-Martel C, Vernet T. 2008. Penicillin-binding proteins and beta-lactam resistance. FEMS Microbiol Rev. 32:361–385.
  • Zirk M, Buller J, Goeddertz P, Rothamel D, Dreiseidler T, Zöller JE, Kreppel M. 2016. Empiric systemic antibiotics for hospitalized patients with severe odontogenic infections. J Craniomaxillofac Surg. 44:1081–1088.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.